JDD Corner

JDD June 2023 Issue Highlights

The June issue of the Journal of Drugs in Dermatology (JDD) features original articles with topics ranging from pediatric acne, rosacea, androgenetic alopecia, precision medicine, infantile hemangiomas, and many more.  Check out this month’s issue highlights straight from the JDD Editor’s desk:

The Many Faces of Pediatric Acne: A Practical Algorithm for Treatment, Maintenance Therapy, and Skincare Recommendations for Pediatric Acne Patients offers a comprehensive approach to treating and maintaining pediatric acne to help healthcare providers improve outcomes.

The findings of Reduction of Erythema in Moderate-Severe Rosacea by a Low Molecular Weight Heparan Sulfate Analog (HSA) support the use of specially formulated Dermal Repair Creams in topical care regimens.

Ceramide-Containing Adjunctive Skin Care for Skin Barrier Restoration During Acne Vulgaris Treatment revealed that these skincare products were effective in reducing the severity and occurrence of dryness, erythema, and scaling.

A Real-World, Open-Label Study of the Efficacy and Safety of a Novel Serum in Androgenetic Alopecia presents evidence of significant improvements in diverse patients and suggests the need for additional clinical studies to further investigate the benefits.

The authors of Neurogenic Rosacea Treatment: A Literature Review propose that combination therapies yield positive results for individuals suffering from neurogenic rosacea.

Cross-Sectional Study of Psoriasis, Atopic Dermatitis, Rosacea, and Alopecia Areata Suggests Association With Cardiovascular Diseases discusses the results of its 70K patient investigation and identifies significant associations between ISDs and several CVD diagnoses.

Unmet Needs in the Management of Acne Vulgaris: A Consensus Statement identifies the role of clascoterone in acne therapy for various types of patients.

Integrating Precision Medicine into Medical Dermatology Clinical Practice: An Expert Consensus Panel presents 10 consensus statements that seek to improve the efficiency and effectiveness for individual patients.

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangiomas shares their observations compiled from a group of 140+ infants with Fitzpatrick skin types IV or V.

In Diacerein 1% Ointment for the Treatment of Epidermolysis Bullosa Simplex: A Randomized, Controlled Trial the authors propose the potential clinical benefits of the ointment’s increased concentration or duration of use in patients with severe EBS.

When applied strategically, the Placement of High-Dose Neurotoxins for Treatment-Resistant Rosacea may prove to be a highly effective option for refractory flushing rosacea.

The observations presented in Role of Retinoic Acid Receptor Subtypes in the Pathophysiology of Acne call for greater research to fully inform the management of this condition.

This research’s findings support that Increased Adalimumab Doses Are Associated With Clinical Improvement of Hidradenitis Suppurativa for overweight/obese patients.

This Letter to the Editor calls attention to Gender-Affirming Hormone Therapy Among Transgender and Gender Diverse Patients Receiving Laser Hair Removal Prior to Gender-Affirming Surgery and dermatologists’ critical role in understanding the effects of this treatment.

This Letter to the Editor, Biologic Versus Conventional Therapies: Comparing Risk of Psoriasis-Associated Comorbidities indicates that biologic therapies are correlated with reduced risk and decreased presence of several psoriasis-associated comorbidities.

Find more JDD Issue Highlights here